United States · Series A startup
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Funding summaryUpdated 26 Oct 2026
$180Mraised across 1 round since 2026, from 2 sources
Frazier Life SciencesLead
Venrock
RA Capital Management
Novo Holdings
Forbion Capital Partners
Longitude Capital
Abingworth
Deep Track CapitalReported by Frazier Life Sciences and 1 other
Missing a round, or an investor who was in one? Tell us.
cAMPfield Therapeutics, Inc.'s investors include Frazier Life Sciences, Venrock, RA Capital Management, Novo Holdings and Forbion Capital Partners, and 3 more on record. Frazier Life Sciences led its latest round.
cAMPfield Therapeutics, Inc. has raised $180M across 1 round since 2026.
cAMPfield Therapeutics, Inc.'s most recent round was a Series A of $180M in Jun 2026, led by Frazier Life Sciences.
Its most recent round, $180M in Jun 2026, is also its largest on record.
cAMPfield Therapeutics, Inc.'s first round on record, in Jun 2026, was backed by Frazier Life Sciences, Venrock and RA Capital Management and 5 others.
cAMPfield Therapeutics, Inc.'s latest named round is a Series A, in Jun 2026.
cAMPfield Therapeutics, Inc. is based in the United States.
Frazier Life Sciences led the Series A in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
